Skip to main content

BAK · Braskem SA

Track BAK — free
$0.77 -0.07 (-8.77%)
Market Cap
$190.95M
Shares
225.95M
Volume · Nov 20 161.69K Avg daily vol (3M) 2.57M

Price & Indicators

 

Key stats

Close
$0.85
Thu 19 Nov
Open
$0.83
Thu 19 Nov
Average volume, 30 days
2.8M
shares a session
Short interest
5.4M
2.4% of shares · 1.3 days to cover
Day range
$0.83$0.88
Open $0.83 Close $0.85
52-week closing range
$0.85$5.02
Close $0.85 83.2% under the high
Short volume, last session
48%
Last earnings
Aug 14, 2026
Price history
Jan 2020 to Nov 2026

Up next

Dec 11, 2026 Scheduled · in 3 wks

Latest documents

2026
Nov 19
Current report 6-K
Board Approves Internal Rules for Safety, Environment and Health Committee

Braskem's board approved on October 22, 2026 internal rules for the Safety, Environment and Health Committee, which advises the board. The committee has three to six members with two-year terms and meets ordinarily monthly.

4 source passages
These Internal Regulations were approved at the ordinary meeting of Braskem's Board of Directors held on October 22, 2026, and will be made available on the Company's website. The CSMS is composed of at least three (3) and up to six (6) members appointed by the Board of Directors The term of office of the CSMS members shall be two (2) years and shall coincide with the term of office of the Board of Directors. meets ordinarily monthly, according to the approved Annual Calendar Open the document at this passage
Nov 19
Current report 6-K
Board approves internal rules for strategy and sustainability committee

Braskem S.A.'s board approved internal rules for its Strategy, Sustainability and Communication Committee on October 22, 2026. The committee has at least three and up to six members and meets at least six times a year.

3 source passages
These Internal Rules were approved at the ordinary meeting of Braskem's Board of Directors held on October 22, 2026 and will be made available on the Company's website. The CESC is composed of at least three (3) and up to six (6) members appointed by the Board of Directors The CESC develops its activities primarily through working meetings and, for this purpose shall meet ordinarily at least six (6) times per year Open the document at this passage
Nov 13
Current report 6-K
Braskem posts US$ 382 million recurring EBITDA in 3Q26

Braskem reported consolidated recurring EBITDA of US$ 382 million in 3Q26, mainly reflecting normalized international spreads, and recurring cash generation of US$ 416 million.

3 source passages
Consolidated recurring EBITDA was US$ 382 million in 3Q26, impacted mainly by the normalization of international spreads Recurring cash generation of US$ 416 million in 3Q26, driven by a positive change in working capital Source: Braskem Open the document at this passage
Nov 13
Current report 6-K
Recurring EBITDA falls 63%; net loss reaches US$206 million

Braskem reported consolidated Recurring EBITDA of US$382 million in 3Q26, down 63% from 2Q26 as petrochemical spreads normalized, and a net loss attributable to shareholders of US$206 million. Operating cash generation was R$2.2 billion, while financial leverage ended at 6.36x.

Read from the first part of this long document
4 source passages
These movements led to a normalization of petrochemical spreads in the international market, which returned to levels closer to those observed before the onset of geopolitical tensions, after the peak recorded in the previous quarter, impacting the Company's consolidated Recurring EBITDA, which amounted to US$382 million in the third quarter of 2026, 63% lower compared to 2Q26. In 3Q26, the Company recorded a net loss attributable to shareholders of US$206 million (R$1.1 billion), mainly due to (i) lower gross profit, explained by the normalization of chemical and petrochemical spreads in the international market, which returned to levels closer to those observed before the onset of geopolitical tensions in the Middle East; and (ii) lower profit before income tax associated with the negative foreign exchange variation of US$19 million (R$100 million). In 3Q26, operating cash generation was R$2.2 billion, mainly due to the positive change in working capital of approximately R$1.0 billion in the quarter. Considering the other effects and the disbursements related to the geological event in Alagoas, cash generation before debt totaled R$2.0 billion in the quarter. In this scenario, financial leverage at the end of the third quarter of 2026 was 6.36x. Open the document at this passage
All documents

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.62
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −70%
below
Price vs 50-day avg −43%
below
RSI (14) 27
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −47%
trailing
6-month return −79%
trailing
YTD return −71%
this year
Relative strength −74%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow Distributing
-18% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.39% of shares out · ▼ -29.0% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
51 holders — mid 3-yr range
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 92%
annualized · 1-yr
Max drawdown −83%
past year
ATR 16.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2020
Demand growth in the market · third quarter up to 10%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−70% Bearish
Price vs 50-day avg
−43% Bearish
RSI (14)
27 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $1 › 200d $3 — 200d above 50d
Institutional flow Distributing
-18% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.39% of shares out · ▼ -29.0% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
51 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $5
vs 200-day avg -70% vs 50-day avg -43%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BAK
Braskem SA
this stock
$190.95M -71.4% — — 2.4%
SHECF
Shin-Etsu Chemical Co., Ltd.
$60.91B +4.8% — — 0.1%
DOW
Dow Inc.
$21.90B +29.4% -7.0% — 3.8%
CE
Celanese Corp
$5.20B +12.1% -7.1% 20.0 5.6%
MEOH
Methanex Corp
$4.88B +58.8% — — 3.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
51
% held
4.5%
Net QoQ
-8.6M sh
Top holder
MARSHALL WACE, LLP
Held Float
View
Held by Funds
Fund positions
6
View
Short & Settlement
Short Interest Falling
Shares short
5.4M
Days to cover
1.3d
Change
-2.2M sh
View
Short Volume
Short vol %
48%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
57.2K
Value
$66.3K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
40.6%
Week of
Oct 12, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 19, 2026
This year
161

Braskem's board approved on October 22, 2026 internal rules for the Safety, Environment and Health Committee, which advises the board. The committee has three to six members with two-year terms and meets ordinarily monthly.

View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 11, 2026
Last webcast
Nov 13, 2026
View
Investor Relations
Upcoming events
3
View

Performance

5D 20D 120D MTD YTD
BAK -25.2% -47.2% -79.4% -27.2% -71.4%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -19.8% -40.9% -73.8% -21.9% -76.3%

Capital returns

Latest dividend
$0.674 / share · ex Apr 20, 2022
Cut 75.1%
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1071438 CUSIP 105532105 13F (30d) 61 filings 52 filers Visit website Investor relations